Allura Xper Product Usage: Vascular,cardiovascular and neurovascular imaging applications,i...

FDA Device Recall #Z-2498-2018 — Class II — June 11, 2018

Recall Summary

Recall Number Z-2498-2018
Classification Class II — Moderate risk
Date Initiated June 11, 2018
Status Terminated
Voluntary FDA Mandated

Recalling Firm

Firm Philips Healthcare
Location Andover, MA
Product Type Devices
Quantity 459 affected systems

Product Description

Allura Xper Product Usage: Vascular,cardiovascular and neurovascular imaging applications,including diagnostic, interventional and minimally invasive procedures. Cardiac imaging applications including diagnostics, interventional and minimally invasive procedures (such as PTCA,stent placing,atherectomies), pacemaker implantat ions, and electrophysiology (EP). Non-vascular interventions such as drainages,biopsies and vertebroplasties procedures.

Reason for Recall

The first time an operator selects a new procedure type during a single examination,the shutter position resets to the open position for the new procedure type. If the shutters had previously been changed during the examination, that setting is not retained after the first time the procedure type is changed during a single examination.

Distribution Pattern

US Nationwide Distribution

Lot / Code Information

Allura 8.1.25 Allura 8.1.25.1 Allura 8.1.25.5 Allura 8.2.25 Allura 8.2.25.5 Allura 8.2.27

Other Recalls from Philips Healthcare

Recall # Classification Product Date
Z-2520-2023 Class II Incisive CT, software version 5.0 Aug 2, 2023
Z-0737-2022 Class II Philips StentBoost Live R2.0 application, when ... Feb 2, 2022
Z-0238-2022 Class II Philips Azurion systems with software releases ... Sep 24, 2021
Z-0241-2022 Class II CombiDiagnost R90 is multi-functional general R... Sep 22, 2021
Z-0239-2022 Class II DigitalDiagnost C90 Sep 22, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.